PIM
RMD icon

Provident Investment Management’s ResMed RMD Stock Holding History

Provident Investment Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-4,900
Closed -$352K – 51
2015
Q1 		$352K Sell
4,900
-3,031
-38% -$197K 0.07% 44
2014
Q4 		$445K Sell
7,931
-1,194
-13% -$62.3K 0.1% 39
2014
Q3 		$450K Sell
9,125
-338,977
-97% -$17.3M 0.1% 39
2014
Q2 		$17.6M Buy
348,102
+3,953
+1% +$196K 4.16% 13
2014
Q1 		$15.4M Buy
344,149
+17,798
+5% +$799K 3.81% 15
2013
Q4 		$15.4M Buy
326,351
+13,671
+4% +$692K 3.9% 14
2013
Q3 		$16.5M Buy
+312,680
New +$15.2M 4.5% 11

Other funds holding RMD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Provident Investment Management's RMD Position: Q2 2015 in Review

Provident Investment Management sold out of ResMed (RMD) in Q2 2015, closing a stake of 4,900 shares — an estimated $352K sold.

Provident Investment Management first reported a position in RMD in Q3 2013 and held it in 7 quarters. The position peaked at $17.6M in Q2 2014. 313 funds tracked by Wall St. Rank hold RMD as of Q2 2015.

  • Provident Investment Management reported no remaining ResMed position as of Q2 2015 after selling out during the quarter.
  • Provident Investment Management sold 4,900 ResMed shares in Q2 2015, an estimated $352K.
  • Provident Investment Management first reported a position in ResMed in Q3 2013 and held it in 7 quarters.
  • Provident Investment Management's ResMed position peaked at $17.6M in Q2 2014.
  • 313 funds tracked by Wall St. Rank held ResMed as of Q2 2015.

Based on Provident Investment Management's 13F filing for Q2 2015, filed 7 Aug 2015.